These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1449040)

  • 41. Immunoreactivity of plasma parathyrin-related peptide: three region-specific radioimmunoassays and a two-site immunoradiometric assay compared.
    Ratcliffe WA; Norbury S; Stott RA; Heath DA; Ratcliffe JG
    Clin Chem; 1991 Oct; 37(10 Pt 1):1781-7. PubMed ID: 1845254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
    Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
    J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased parathyroid hormone-related peptide in patients with hypercalcemia associated with islet cell carcinoma.
    Wu TJ; Lin CL; Taylor RL; Kvols LK; Kao PC
    Mayo Clin Proc; 1997 Dec; 72(12):1111-5. PubMed ID: 9413289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parathyroid hormone-related protein in tumor tissues obtained from patients with humoral hypercalcemia of malignancy.
    Tsuchihashi T; Yamaguchi K; Miyake Y; Otsubo K; Nagasaki K; Honda S; Akiyama Y; Maeda Y; Koike M; Alper O
    J Natl Cancer Inst; 1990 Jan; 82(1):40-4. PubMed ID: 2293655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
    Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels.
    Kovacs CS; Chik CL
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3036-42. PubMed ID: 7559893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of serum concentration of parathyroid hormone-related protein and its implication in hypercalcemia in squamous cell carcinoma of the head and neck.
    Rikimaru K; Matsumoto F; Hayashi E; Bando H; Nagayama M
    Int J Oral Maxillofac Surg; 1995 Oct; 24(5):365-8. PubMed ID: 8627105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia.
    Budayr AA; Nissenson RA; Klein RF; Pun KK; Clark OH; Diep D; Arnaud CD; Strewler GJ
    Ann Intern Med; 1989 Nov; 111(10):807-12. PubMed ID: 2817628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parathyroid-hormone-related peptide in hematologic malignancies.
    Kremer R; Shustik C; Tabak T; Papavasiliou V; Goltzman D
    Am J Med; 1996 Apr; 100(4):406-11. PubMed ID: 8610726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parathyroid hormone-related protein as a tumour marker in humoral hypercalcaemia associated with occult malignancy.
    Hutchesson AC; Dunne F; Bundred NJ; Gee H; Ratcliffe WA
    Postgrad Med J; 1993 Aug; 69(814):640-2. PubMed ID: 7880211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
    Rizzoli R; Thiébaud D; Bundred N; Pecherstorfer M; Herrmann Z; Huss HJ; Rückert F; Manegold C; Tubiana-Hulin M; Steinhauer EU; Degardin M; Thürlimann B; Clemens MR; Eghbali H; Body JJ
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3545-50. PubMed ID: 10522993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measurement of circulating parathyroid hormone-related protein in rats with humoral hypercalcemia of malignancy using a two-site immunoradiometric assay.
    Gaich G; Burtis WJ
    Endocrinology; 1990 Sep; 127(3):1444-9. PubMed ID: 2387260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevation of circulating plasma cytokines in cancer patients with high plasma parathyroid hormone-related protein levels.
    Takahashi S; Hakuta M; Aiba K; Ito Y; Horikoshi N; Miura M; Hatake K; Ogata E
    Endocr Relat Cancer; 2003 Sep; 10(3):403-7. PubMed ID: 14503917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular forms of parathyroid hormone-related protein in tumours and biological fluids.
    Bowden SJ; Hughes SV; Ratcliffe WA
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):287-94. PubMed ID: 8458100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapy.
    Body JJ; Dumon JC; Thirion M; Cleeren A
    J Bone Miner Res; 1993 Jun; 8(6):701-6. PubMed ID: 8328312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
    Syed MA; Horwitz MJ; Tedesco MB; Garcia-Ocaña A; Wisniewski SR; Stewart AF
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parathyroid hormone-related protein in patients with primary breast cancer and eucalcemia.
    Bucht E; Rong H; Pernow Y; Nordqvist AC; Eriksson E; Rankin W; von Schoultz E; Burtis WJ; Granberg B; Falkmer UG; Burton DW; Deftos LJ
    Cancer Res; 1998 Sep; 58(18):4113-6. PubMed ID: 9751621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour.
    Mantzoros CS; Suva LJ; Moses AC; Spark R
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):373-5. PubMed ID: 9156050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status.
    Stiegler C; Leb G; Kleinert R; Warnkross H; Ramschak-Schwarzer S; Lipp R; Clarici G; Krejs GJ; Dobnig H
    J Bone Miner Res; 1995 May; 10(5):751-9. PubMed ID: 7639111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat model.
    Schilling T; Blind E; Baier R; Sinn HP; Moallem E; Silver J; Ziegler R; Raue F
    J Bone Miner Res; 1995 Jan; 10(1):7-16. PubMed ID: 7747633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.